- ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer<p>At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.</p>BioPharma Dive · 1mo ago↗ source
- Why US-manufactured pharmaceutical packaging equipment matters<p>As manufacturers modernize operations, the origin of their equipment is a strategic consideration.</p>BioPharma Dive · 1mo ago↗ source
- Opinion: The virtual end of the doctor’s office waiting roomIt’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.STAT · 1mo ago↗ source